Holen Sie sich die Stockscreener-App
2.78
7.34%
0.19
Handel nachbörslich:
2.78
Schlusskurs vom Vortag:
$2.59
Offen:
$2.61
24-Stunden-Volumen:
735.43K
Relative Volume:
1.10
Marktkapitalisierung:
$199.42M
Einnahmen:
$405.47M
Nettoeinkommen (Verlust:
$53.66M
KGV:
3.8611
EPS:
0.72
Netto-Cashflow:
$131.28M
1W Leistung:
+3.15%
1M Leistung:
+16.32%
6M Leistung:
-14.46%
1J Leistung:
-29.08%
1-Tages-Spanne:
$2.61
$2.81
1-Wochen-Bereich:
$2.59
$2.81
52-Wochen-Spanne:
$2.08
$4.22
Orasure Technologies Inc Stock (OSUR) Company Profile
Firmenname
Orasure Technologies Inc
Sektor
Telefon
(503) 641-6115
Adresse
220 E FIRST ST, BETHLEHEM, PA
Vergleichen Sie OSUR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OSUR
Orasure Technologies Inc
|
2.78 | 185.79M | 405.47M | 53.66M | 131.28M | 0.72 |
|
ISRG
Intuitive Surgical Inc
|
523.69 | 186.98B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
206.18 | 57.95B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
81.62 | 38.83B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
259.28 | 36.96B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
43.30 | 36.74B | 27.43B | 1.27B | 1.01B | 1.5829 |
Orasure Technologies Inc Stock (OSUR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-01-03 | Fortgesetzt | Evercore ISI | In-line |
| 2021-09-22 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2020-08-21 | Eingeleitet | Evercore ISI | Outperform |
| 2020-08-10 | Eingeleitet | Citigroup | Buy |
| 2020-08-10 | Eingeleitet | JP Morgan | Neutral |
| 2020-08-07 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-06-25 | Eingeleitet | Lake Street | Buy |
| 2020-04-21 | Fortgesetzt | Stephens | Equal-Weight |
| 2018-10-23 | Fortgesetzt | Raymond James | Mkt Perform |
| 2018-07-16 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2017-11-02 | Herabstufung | Jefferies | Buy → Hold |
| 2017-02-09 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2016-06-13 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-11-05 | Bestätigt | Mizuho | Buy |
| 2015-05-07 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2015-01-23 | Bestätigt | Mizuho | Buy |
| 2014-06-12 | Bestätigt | Canaccord Genuity | Buy |
| 2014-06-11 | Bestätigt | Mizuho | Buy |
| 2012-12-21 | Eingeleitet | Mizuho | Buy |
| 2012-08-08 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2012-07-05 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2012-03-27 | Eingeleitet | JMP Securities | Mkt Outperform |
Alle ansehen
Orasure Technologies Inc Aktie (OSUR) Neueste Nachrichten
Is OraSure Technologies Inc. stock attractive for growth ETFsPortfolio Value Report & Verified Short-Term Plans - bollywoodhelpline.com
The Truth About OraSure Technologies: Is This ‘Boring’ Test Maker Your Next Viral Money Play? - AD HOC NEWS
Altai Capital nominates two directors for OraSure Technologies board By Investing.com - Investing.com Nigeria
Altai Capital nominates two directors to OraSure board amid concerns By Investing.com - Investing.com Nigeria
Orasure Technologies confirms receipt of director nominations from Altai Capital - marketscreener.com
Orasure Technologies Confirms Receipt Of Director Nominations From Altai Capital - TradingView — Track All Markets
OraSure (OSUR) Faces Board Nomination Challenge for 2026 - GuruFocus
Altai Capital nominates two directors for OraSure Technologies board - Investing.com
OraSure Technologies Confirms Receipt of Director Nominations from Altai Capital - GlobeNewswire
Altai Capital nominates two directors to OraSure's board (update) (OSUR:NASDAQ) - Seeking Alpha
Altai Capital nominates two directors to OraSure board amid concerns - Investing.com
Altai pushes OraSure (NASDAQ: OSUR) board shakeup with two nominees at 2026 annual meeting - Stock Titan
Altai Capital Management Submits a Notice of its Intention to Nominate Candidates to OraSure Technologies Inc - marketscreener.com
Altai Capital Management Nominates Two Highly-Qualified Candidates for Election to OraSure Board of Directors - marketscreener.com
Aug Spikes: Is OraSure Technologies Inc stock undervalued vs historical averagesWeekly Stock Report & Weekly Consistent Profit Watchlists - Bộ Nội Vụ
Value Recap: Is OraSure Technologies Inc part of any major index2025 Major Catalysts & Accurate Trade Setup Notifications - baoquankhu1.vn
Movement Recap: Is OraSure Technologies Inc attractive for institutional investorsStop Loss & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
Aug Catalysts: How OraSure Technologies Inc stock trades before earnings2025 Short Interest & Safe Capital Growth Tips - Bộ Nội Vụ
Will OraSure Technologies Inc. stock deliver better than expected guidance2025 Technical Patterns & Consistent Return Strategy Ideas - Улправда
How OraSure Technologies Inc. stock trades before earningsJuly 2025 Sector Moves & Daily Volume Surge Trade Alerts - ulpravda.ru
OraSure submits CT/NG molecular self-test, Colli-Pee device for FDA review - MSN
OraSure Technologies (OSUR) Price - Zacks Investment Research
OraSure seeking FDA approval for pair of products - WFMZ.com
OraSure Files for FDA Review of Molecular Self-Test & Colli-Pee Device - sharewise.com
OraSure submits FDA applications for rapid STI test and collection device - Investing.com Nigeria
OraSure (OSUR) Seeks FDA Approval for New Diagnostic Solutions - GuruFocus
OraSure Seeks FDA Clearance for New STI Tests - TipRanks
OraSure submits FDA applications for rapid STI test and collection device By Investing.com - Investing.com South Africa
OraSure Technologies, Inc. Submits FDA Applications for Rapid Self-Test for STIs and At-Home Urine Collection Device - Quiver Quantitative
OraSure Submits CT/NG Molecular Self-Test and Colli-Pee™ Urine Collection Device for FDA Review - The Manila Times
OraSure Technologies Inc Submits FDA Applications for Diagnostic Devices - TradingView — Track All Markets
OraSure submits two diagnostic tests to FDA for clearance - StreetInsider
OraSure Technologies Stock Jump Looks Great, But How Secure Is That Gain? - Trefis
Is OraSure Technologies Inc. (EP3) stock good for long term investingJuly 2025 Catalysts & Consistent Profit Trade Alerts - Улправда
Investment Recap: Can OraSure Technologies Inc. stock surprise with earnings upsideWeekly Risk Report & Daily Chart Pattern Signal Reports - Улправда
Can OraSure Technologies Inc. stock maintain operating margins2025 Technical Patterns & Low Risk High Reward Ideas - Улправда
Can OraSure Technologies Inc. stock surprise with earnings upsideJuly 2025 Catalysts & Low Risk High Reward Ideas - Улправда
Hedge fund confirms boardroom battle brewing at OraSure - WFMZ.com
Report: Businessman upping pressure amid buyout attempt of OraSure - wfmz.com
OraSure Technologies Earnings Notes - Trefis
OraSure Technologies Issues Statement Regarding Altai Capital?s Intent to Nominate Director Candidates - marketscreener.com
OraSure issues statement regarding Altai's intent to nominate director candidates - marketscreener.com
OraSure (OSUR) Responds to Altai Capital's Board Nominee Proposa - GuruFocus
Altai Capital to nominate directors to OraSure board amid concerns By Investing.com - Investing.com Nigeria
Altai Capital to nominate two board candidates at OraSure Technologies By Investing.com - Investing.com Nigeria
OraSure Confirms Altai Capital's Intention of Board Nominations - marketscreener.com
Altai Capital to nominate two board candidates at OraSure Technologies - Investing.com
OraSure Technologies Confirms Altai Capital's Nomination of Board Candidates Ahead of 2026 Annual Meeting - Quiver Quantitative
OraSure Technologies Issues Statement Regarding Altai Capital’s Intent to Nominate Director Candidates - StreetInsider
Altai Capital Announces Intention to Nominate Candidates for Election to OraSure Board - marketscreener.com
Finanzdaten der Orasure Technologies Inc-Aktie (OSUR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Orasure Technologies Inc-Aktie (OSUR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Gagliano Nancy J | Director |
Nov 28 '25 |
Buy |
2.37 |
2,100 |
4,982 |
160,254 |
| Gagliano Nancy J | Director |
Feb 27 '25 |
Buy |
3.08 |
12,750 |
39,270 |
91,524 |
| EGLINTON MANNER CARRIE | President & CEO |
Feb 28 '25 |
Buy |
3.49 |
28,670 |
100,027 |
1,288,334 |
| EGLINTON MANNER CARRIE | President & CEO |
Feb 27 '25 |
Buy |
3.15 |
78,625 |
247,378 |
1,259,664 |
| Kenny John P. | Director |
Feb 27 '25 |
Buy |
3.17 |
47,659 |
151,217 |
70,915 |
| McGrath Kenneth J | Chief Financial Officer |
Feb 27 '25 |
Buy |
3.15 |
64,000 |
201,683 |
371,013 |
| Marmora Lelio | Director |
Feb 27 '25 |
Buy |
3.06 |
7,000 |
21,420 |
67,720 |
1.77%
0.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):